Evidence map›Paper›PMID 37701550›Full record

ArticleCanadian journal of pain = Revue canadienne de la douleur2023

Views on and experiences with medicinal cannabis among Canadian veterans who live with pain: A qualitative study.

David P Storey, Natalie R Keeler-Villa, Nick Harris, Jennifer Anthonypillai, Gregory K Tippin, Vikas Parihar, Joshua A Rash

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian journal of pain = Revue canadienne de la douleur, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

David P StoreyDepartment of Psychology, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.ORCID https://orcid.org/0000-0001-5757-6922
Natalie R Keeler-VillaDepartment of Psychology, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.ORCID https://orcid.org/0000-0002-9514-0203
Nick HarrisDepartment of Psychology, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.ORCID https://orcid.org/0000-0003-3779-4302
Jennifer AnthonypillaiMichael G. DeGroote Pain Clinic, Hamilton Health Sciences, Hamilton, Ontario, Canada.ORCID https://orcid.org/0009-0002-7778-5566
Gregory K TippinMichael G. DeGroote Pain Clinic, Hamilton Health Sciences, Hamilton, Ontario, Canada.ORCID https://orcid.org/0000-0001-5995-0076
Vikas PariharMichael G. DeGroote Pain Clinic, Hamilton Health Sciences, Hamilton, Ontario, Canada.ORCID https://orcid.org/0000-0002-3369-5908
Joshua A RashDepartment of Psychology, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.ORCID https://orcid.org/0000-0003-0927-0712
Memorial University of Newfoundland · CAHamilton Health Sciences · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: During fiscal year 2021-2022, Veterans Affairs Canada (VAC) reimbursed 18,388 veterans for medicinal cannabis at a cost of $153 million. Yet, it is not known whether the reimbursement program is producing a net benefit for veterans. Aims: This study investigated the views and experiences Canadian that veterans who live with pain have about medicinal cannabis use, including its use for the management of chronic pain, poor sleep, and emotional distress. Methods: Twelve Canadian veterans who live with pain-eight men, four women; split across four focus groups-were recruited to participate in a semistructured discussion around their experiences with medicinal cannabis use. Results: Using inductive thematic analysis, seven broad categories were identified: (1) cannabis use behaviors, (2) reasons for cannabis use, (3) outcomes from cannabis use, (4) facilitators of cannabis use, (5) barriers to cannabis use, (6) stigma around cannabis use, and (7) questions and concerns about cannabis use. Conclusions: Most veterans initiated cannabis use to manage the symptoms of preexisting medical and/or mental health conditions. Despite some negative side effects, most veterans reported improvements in their overall quality of life, sleep, relationships, mood, and pain. Concern remains around the discrepancy between veterans' qualitative reports of beneficial outcomes from medicinal cannabis use and equivocal findings around the benefit-to-harm ratio in the wider literature. Currently, the VAC reimbursement program remains challenged by unclear indication for which veterans, with what condition(s), at what dose, and in what form medical cannabis is most beneficial.

Indexed as

Cannabinoidschronic painmedical cannabismilitaryqualitative researchVeterans

Identifiers

PMID37701550
PMCPMC10494725
OpenAlexW4383341255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.